Wells Fargo Downgrades St. Jude Medical (STJ) to Market Perform

Go back to Wells Fargo Downgrades St. Jude Medical (STJ) to Market Perform

St. Jude Medical (STJ) Says Loss of Selling Week Responsible for Reduced Revenue - Needham & Company Cut PT to $71

January 21, 2016 6:53 AM EST

Needham & Company maintained a Strong Buy rating on St. Jude Medical (NYSE: STJ), and cut the price target to $71.00 (from $85.00), following the company's pre-announced 4Q revenue below consensus. Management is citing that there was one less selling week in the 4Q, reducing the... More